{"disease":{"id":"elevated-cholesterol","name":"elevated cholesterol"},"drugs":{"marketed":[{"drug_id":"lopid","indication_name":"Reducing risk of developing coronary heart disease in Type IIb patients without history or symptoms of existing coronary heart disease with low HDL-cholesterol, elevated LDL-cholesterol, and elevated triglycerides unresponsive to weight loss, diet, exercise, and other pharmacologic agents","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopid","generic_name":"Gemfibrozil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"PPAR-alpha (Peroxisome Proliferator-Activated Receptor Alpha)","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":44,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03814187","title":"Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3275,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04798430","title":"Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"LIB Therapeutics LLC","has_results":false},{"nct_id":"NCT03400800","title":"Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1617,"lead_sponsor_name":"The Medicines Company","has_results":true},{"nct_id":"NCT03399370","title":"Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1561,"lead_sponsor_name":"The Medicines Company","has_results":true},{"nct_id":"NCT04807400","title":"Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":892,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03397121","title":"Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":482,"lead_sponsor_name":"The Medicines Company","has_results":true},{"nct_id":"NCT07368608","title":"A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":340,"lead_sponsor_name":"BeBetter Med Inc","has_results":false},{"nct_id":"NCT06222632","title":"Cardioprotective and Mental Health Benefits of the MIND Diet Combined With Forest Bathing","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":273,"lead_sponsor_name":"Tung Wah College","has_results":false},{"nct_id":"NCT03911427","title":"Oat and Cholesterol","phase":"NA","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"PepsiCo Global R&D","has_results":false},{"nct_id":"NCT04403789","title":"Effects of a Workplace Exercise Intervention on Cardio-Metabolic Health","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"United Arab Emirates University","has_results":false},{"nct_id":"NCT07255820","title":"Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":126,"lead_sponsor_name":"Bahria University","has_results":false},{"nct_id":"NCT05091073","title":"A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07428473","title":"A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Monash University","has_results":false},{"nct_id":"NCT05181553","title":"Unravelling the Impact of Diet on Cardiovascular Health in Heterozygous Familial Hypercholesterolemia.","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Laval University","has_results":false},{"nct_id":"NCT05896969","title":"Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Syneos Health","has_results":false},{"nct_id":"NCT03134235","title":"Effects of a 4-week Raw, Plant-based Diet on Anthropometric and Cardiovascular Risk Factors","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Texas Woman's University","has_results":false},{"nct_id":"NCT06693947","title":"Impact of Alpine Dairy Products on Blood Lipid Levels","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Fribourg","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}